DirectoryMix Web Resources » Article Details

NEWS FEATURE: Research bots leverage open-source for child-like intelligence - Read More

Date Added: July 13, 2008 05:52:03 AM
Researchers from across Europe are being trained in Genoa, Italy, this month in advance of taking possession of their very own iCub: a robot designed to have the physical and sensory capabilities of a two-and-a-half year old child.

Category: Science and Technology » Cognitive Science


No comments are posted yet


 
Name:*
Email:*
Website:  (optional)
Comment:*
(html and bb codes are filtered and not allowed)

Do the math:*CAPTCHA - Do The Math
 

Related Articles

News Brief | $10 million donated to Cognitive Center

Penn is leading the way in learning how the mind works. The University is part of a consortium that received a $10 million grant for five years from the U.S. Department of Education's Institute of Education Sciences to establish a 21st Century Center for

Are HDTVs the office 'windows' of the future?

While some might think plasma screens showing tumbling waterfalls or crackling fireplaces can help alleviate stress, researchers say it won't do much good, even if it is high-definition.

Wounded Pakistani woman faces US judge

A Pakistani mother who graduated from a top US university, then vanished five years ago, has been charged in New York with attempted murder of US officers in Afghanistan, in a case prompting protests from her homeland.

Train Your Brain: 'Brain fitness' market booming with boomers

Teenagers cramming for tests and people worried about "senior moments" can now turn to an explosion of brain-assisting video games, such as Nintendo's Brain Age; puzzles that are said to ward off dementia, such as Sudoku and crosswords; and online tips

Phase II Data On Lilly's Antibody Show It Affects Amyloid Beta, A Protein Believed To Be Associated With Alzheimer's ...

Eli Lilly and Company (NYSE: LLY) announced interim results of its Phase II study of LY2062430, an investigational anti-amyloid beta monoclonal antibody for the treatment of mild to moderate Alzheimer's disease.